Insights

Filters
clear all
Filters
Topics
Industry
Type
Workers' Comp Article

Modifications to Living Spaces Make Injured Workers Feel at Home

1 MIN READ

When a 33-year-old man was grievously injured at work, the last thing he might have expected he would need as part of his recovery was a real estate agent.

Auto Casualty CE Webinar

Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In [On-Demand Webinar]

On-Demand

In this on-demand webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.

Workers' Comp Article

Catastrophic Claims Often Require Nuanced Solutions

8 MIN READ

In workers’ compensation, catastrophic injuries transpire with relatively low frequency. When they do occur, however, payers demand an all-hands-on-deck approach that calls upon specialized experts to manage specific aspects of these complicated claims.

Enlyte Article

FDA Approves Combination NSAID/Opioid Seglentis

2 MIN READ

On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).

Enlyte Article

FDA Approves Combination NSAID/Opioid Seglentis

2 MIN READ

On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA). Seglentis contains tramadol, a short-acting opioid, and celecoxib, a non-steroidal anti-inflammatory drug (NSAID), and is indicated for adults in the management of acute pain that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

PDF Article

Specialty Services Are a Big Deal

1 MIN READ

When adjusters have to jump through hoops to make referrals, they lose precious time. When it comes to specialty services, we have your back.

Mitchell Virtual Event

Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In

On-Demand

In this upcoming webinar, hear the latest from Enlyte experts on Michigan’s no-fault fee schedule, including product info and regulatory changes.

Media Coverage

See Why Enlyte Keeps Making Headlines

Read More
Media Kit

Access the Enlyte Media Kit

Media Kit